JSA
IDXX icon

Jacobson & Schmitt Advisors’s Idexx Laboratories IDXX Stock Holding History

Jacobson & Schmitt Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.3M Buy
15,764
+398
+3% +$223K 1.36% 30
2026
Q1 		$8.63M Sell
15,366
-4,918
-24% -$3.15M 1.57% 29
2025
Q4 		$13.7M Buy
20,284
+179
+0.9% +$122K 2.31% 22
2025
Q3 		$12.8M Sell
20,105
-6,794
-25% -$4.12M 2.2% 24
2025
Q2 		$14.4M Buy
26,899
+1,912
+8% +$914K 2.56% 19
2025
Q1 		$10.5M Buy
+24,987
New +$10.8M 2.14% 24

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Jacobson & Schmitt Advisors's IDXX Position: Q2 2026 in Review

Jacobson & Schmitt Advisors increased its Idexx Laboratories (IDXX) stake by 2.6% in Q2 2026, buying an estimated $223K and bringing the position to 15,764 shares worth $8.3M. The position accounts for 1.36% of the portfolio, ranked #30.

Jacobson & Schmitt Advisors first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.4M in Q2 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Jacobson & Schmitt Advisors held 15,764 shares of Idexx Laboratories worth $8.3M as of Q2 2026.
  • Jacobson & Schmitt Advisors bought 398 Idexx Laboratories shares in Q2 2026, an estimated $223K.
  • Idexx Laboratories made up 1.36% of Jacobson & Schmitt Advisors's portfolio in Q2 2026, its #30 holding.
  • Jacobson & Schmitt Advisors first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Jacobson & Schmitt Advisors's Idexx Laboratories position peaked at $14.4M in Q2 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Jacobson & Schmitt Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.